INMED PHARMACEUTICALS INC. Disposal Group, Including Discontinued Operation, General and Administrative Expense
INMED PHARMACEUTICALS INC. (INM) reported Disposal Group, Including Discontinued Operation, General and Administrative Expense of $77.74 thousand for the 9-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense · last filed 2023-05-15
- INMED PHARMACEUTICALS INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2023-03-31 was $8.35K.
- INMED PHARMACEUTICALS INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2022-12-31 was $9.44K.
- INMED PHARMACEUTICALS INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2022-09-30 was $59.96K.
| Period end | Disposal Group, Including Discontinued Operation, General and Administrative Expense 3 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 6 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 9 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-03-31 | $8.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $17.78K derived: sum of 2 quarters · filed 2023-05-15 | $77.74K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $9.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-17 | $69.39K 10-Q · filed 2023-02-17 | ||
| 2022-09-30 | $59.96K 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $270.44K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |